US2008108820A1PendingUtilityA1
Hemiasterlin Derivatives and Uses Thereof
Individually held — no corporate assignee on recordPriority: Mar 22, 2002Filed: Sep 22, 2004Published: May 8, 2008
Est. expiryMar 22, 2022(expired)· nominal 20-yr term from priority
Inventors:Silvio CampagnaFrancis G. FangJames J. KowalczykShawn SchillerBoris M. SeletskyMark SpyveeHu Yang
C07D 401/14C07D 401/06C07D 207/04C07D 405/12C07D 209/20C07D 233/84C07K 5/0205C07D 277/06C07D 207/12C07D 237/04C07D 223/06C07D 207/16C07D 217/26C07D 211/60C07K 5/0207C07D 403/06C07D 207/42C07D 265/30C07D 401/12C07K 5/0821A61P 35/00C07D 471/04C07D 279/12C07D 241/04C07K 5/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R 1 -R 7 , X 1 , X 2 , R, Q, and n are as defined herein.
Claims
exact text as granted — not AI-modified1 - 45 . (canceled)
46 . An intermediate having the structure:
wherein g is 1, 2, 3 or 4;
R 2 is hydrogen, or a substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl, heteroalkyl, -alkyl(aryl) or acyl moiety;
R 6 is substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl;
L is CR L1 R L2 , S, O or NR L3 , wherein each occurrence of R L1 , R L2 and R L3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of R G1 , R M1 and R M2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
wherein any two adjacent R L1 , R L2 , R L3 , R G1 , R M1 or R M2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety.
47 - 52 . (canceled)
53 . The intermediate of claim 46 having the structure:
54 - 61 . (canceled)
62 . An intermediate having the structure:
wherein R x1 and R x2 are independently hydrogen, aliphatic, alicyclic or aryl;
g is 1, 2, 3 or 4;
L is CR L1 R L2 , S, O or NR L3 , wherein each occurrence of R L1 , R L2 and R L3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of R G1 , R M1 and R M2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
wherein any two adjacent R L1 , R L2 , R L3 , R G1 , R M1 or R M2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety;
R 2 is hydrogen, —(C═O)R C or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein each occurrence of R c is independently hydrogen, OH, OR D , or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein R D is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
R 6 is hydrogen, —(C═O)R E or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety, wherein each occurrence of R E is independently hydrogen, OH, OR F , or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; wherein R F is an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety.
63 . The intermediate of claim 62 having the structure:
64 . The intermediate of claim 63 wherein R x1 and R x2 are independently hydrogen, alkyl or aryl.
65 . The intermediate of claim 63 wherein R x1 and R x2 are each hydrogen.
66 . The intermediate of claim 53 or 63 wherein R 2 is hydrogen, or a substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl, heteroalkyl, -alkyl(aryl) or acyl moiety.
67 . The intermediate of claim 66 wherein R 2 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH 3 )Et, —CH(CH 3 )CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 ) 2 , —CH(CH 3 )CH(CH 3 ) 2 , —C(CH 3 ) 2 Et, —CH(CH 3 )cyclobutyl, —CH(Et) 2 , —C(CH 3 ) 2 C≡CH, cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl.
68 . The intermediate of claim 66 wherein R 2 is methyl, ethyl, propyl or i-propyl.
69 . The intermediate of claim 53 or 63 wherein R 6 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH 3 )CH 2 CH 3 , —CH 2 CH(CH 3 ) 2 , cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl; and R 2 is methyl, ethyl, propyl, butyl, pentyl, tert-butyl, i-propyl, —CH(CH 3 )Et, —CH(CH 3 )CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 ) 2 , —CH(CH 3 )CH(CH 3 ) 2 , —C(CH 3 ) 2 Et, —CH(CH 3 )cyclobutyl, —CH(Et) 2 , —C(CH 3 ) 2 C≡CH, cyclohexyl, cyclopentyl, cyclobutyl or cyclopropyl.
70 . The intermediate of claim 69 wherein R 6 is tert-butyl.
71 . The intermediate of claim 53 or 63 wherein R G1 is hydrogen, substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl or substituted or unsubstituted phenyl.
72 . The intermediate of claim 71 wherein R G1 is hydrogen, methyl or phenyl.
73 . The intermediate of claim 71 wherein R G1 is hydrogen.
74 . The intermediate of claim 53 or 63 wherein R M1 and R M2 are each independently hydrogen, hydroxyl, a substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl moiety; a substituted or unsubstituted phenyl moiety, or R M2 is absent when R M1 and the substitutents on L, taken together, form a substituted or unsubstituted aryl or heteroaryl moiety.
75 . The intermediate of claim 74 wherein R M1 and R M2 are each hydrogen.
76 . The intermediate of claim 53 or 63 wherein L is CR L1 R L2 wherein R L1 and R L2 are each independently hydrogen, substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl or substituted or unsubstituted phenyl.
77 . The intermediate of claim 76 wherein L is CH 2 .
78 . A method for preparing a compound of formula VI A :
said method comprising steps of:
(a) reacting two compounds having the structures:
under suitable conditions to form a compound having the structure:
(b) oxidizing the compound formed in step (a) under suitable conditions to form a compound having the structure:
(c) subjecting the compound formed in step (b) to suitable olefin-forming conditions to form a compound having the structure:
(d) subjecting the compound formed in step (c) to suitable diversification reactions to generate the desired compound having the structure:
wherein g is 1 or 2;
R Q′ is hydrogen, lower alkyl or an oxygen protecting group;
R 2 and R 6 are independently substituted or unsubstituted linear or branched lower alkyl;
R 10a is hydrogen or substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl;
L is CR L1 R L2 , S, O or NR L3 , wherein each occurrence of R L1 , R L2 and R L3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of R G1 , R M1 and R M2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
wherein any two adjacent R L1 , R L2 , R L3 , R G1 , R M1 or R M2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety.
79 . The method of claim 78 wherein, in the step of oxidizing, the conditions comprise Swern or Dess Martin oxidizing conditions.
80 . The method of claim 78 wherein, in step (c), the olefin-forming conditions comprise Ph 3 P═C(R 10a )CO 2 R Q′ ; wherein R Q′ is hydrogen, lower alkyl or an oxygen protecting group; and R 10a is as defined generally above and in classes and subclasses herein.
81 . A method for preparing a compound of formula VI A :
said method comprising steps of:
(a) reacting two compounds having the structures:
under suitable conditions to form a compound having the structure:
wherein R x1 and R x2 are independently hydrogen, alkyl, heteroalkyl, aryl or heteroaryl;
(b) converting the compound formed in step (a) under suitable conditions to form a compound having the structure:
(c) subjecting the compound formed in step (b) to suitable diversification reactions to generate the desired compound having the structure:
wherein g is 1 or 2;
R Q′ is hydrogen, lower alkyl or an oxygen protecting group;
R 2 and R 6 are independently substituted or unsubstituted linear or branched lower alkyl;
R 10a is hydrogen or substituted or unsubstituted, linear or branched, cyclic or acyclic, or saturated or unsaturated lower alkyl;
L is CR L1 R L2 , S, O or NR L3 , wherein each occurrence of R L1 , R L2 and R L3 is independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety;
each occurrence of R G1 , R M1 and R M2 is each independently hydrogen or an aliphatic, alicyclic, heteroaliphatic, heteroalicyclic, aryl or heteroaryl moiety; and
wherein any two adjacent R L1 , R L2 , R L3 , R G1 , R M1 or R M2 groups, taken together, form a substituted or unsubstituted alicyclic or heteroalicyclic moiety containing 3-6 atoms or an aryl or heteroaryl moiety.
82 . The method of claim 81 wherein the step of converting comprises steps of:
(i) subjecting the compound having the structure:
to ozonolysis conditions to form an aldehyde having the structure:
(ii) subjecting the compound formed in step (i) to suitable olefin-forming conditions to form a compound having the structure:
83 . The method of claim 81 wherein, in step (ii), the olefin-forming conditions comprise Ph 3 P═C(R 10a )CO 2 R Q′ ; wherein R Q′ is hydrogen, lower alkyl or an oxygen protecting group; and R 10a is as defined generally above and in classes and subclasses herein.
84 . The method of claim 81 wherein, the step of converting comprises a step of:
subjecting the compound having the structure:
to cross-olefin-metathesis conditions in the presence of CH 2 ═C(R 10a )CO 2 R Q′ to form a compound having the structure:Join the waitlist — get patent alerts
Track US2008108820A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.